Laboratory investigation: Effects of propofol on the systemic inflammatory response during aortic surgery

Canadian Journal of Anesthesia

Volumn 53, Issue 7, 2006, Pages 701-710

  Rodríguez López, José M ^a   Sánchez Conde, Pilar ^a   Lozano, Francisco S ^a   Nicolás, Juan L ^b   García Criado, Francisco J ^a   Cascajo, Carlos ^a   Muriel, Clemente ^a  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^b Hospital General de Zamora   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; CEFAZOLIN; CREATININE; DIAZEPAM; FENTANYL; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; KETAMINE; MALONALDEHYDE; MIVACURIUM; MYELOPEROXIDASE; OXYGEN RADICAL; PROPOFOL; SEVOFLURANE; SUPEROXIDE; SUPEROXIDE DISMUTASE; THIOPENTAL; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL AORTA; ANESTHESIOLOGICAL TECHNIQUES; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; AORTA CLAMPING; AORTA RECONSTRUCTION; ARTICLE; BLOOD SAMPLING; BYPASS SURGERY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOKINE PRODUCTION; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; EXPERIMENTAL SURGERY; IN VIVO STUDY; KIDNEY BIOPSY; KIDNEY FUNCTION; LIPID PEROXIDATION; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RENAL PROTECTION; SWINE;

EID: 33747624911     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03021629     Document Type: Article

References (42)

1. Ross S, Foex P. Protective effects of anaesthetics in reversible and irreversible ischaemia-reperfusion injury. Br J Anaesth 1999; 82: 622-32.
2. Runzer TD, Ansley DM, Godin DV, Chambers GK. Tissue antioxidant capacity during anesthesia: propofol enhances in vivo red cell and tissue antioxidant capacity in a rat model. Anesth Analg 2002; 94: 89-93.
3. Huang CJ, Slovin PN, Nielsen RB, Skimming JW. Diprivan attenuates the cytotoxicity of nitric oxide in cultured human bronchial epithelial cells. Intensive Care Med 2002; 28: 1145-50.
4. Kato R, Foex P. Myocardial protection by anesthetic agents against ischemia-reperfusion injury: an updater for anesthesiologist. Can J Anesth 2002; 49: 777-91.
5. Ansley DM, Lee JU, Godin DV, Garnett ME, Qayumi AK. Propofol enhances red cell antioxidant capacity in swine and humans. Can J Anaesth 1998; 45: 233-9.
6. Murphy PG, Myers DS, Davies MJ, Webster NR, Jones JG. The antioxidant potential of propofol (2,6-diisopropylphenol). Br J Anaesth 1992; 68: 613-8.
7. Green TR, Bennett SR, Nelson VM. Specificity and properties of propofol as an antioxidant free radical scavenger. Toxicol Appl Pharmacol 1994; 129: 163-9.
8. Kahraman S, Demiryurek AT. Propofol is a peroxynitrite scavenger. Anesth Analg 1997; 84: 1127-9.
9. Mouithys-Mickalad A, Hans P, Deby-Dupont G, Hoebeke M, Deby C, Lamy M. Propofol reacts with peroxynitrite to form a phenoxyl radical: demonstration by electron spin resonance. Biochem Biophys Res Commun 1998; 249: 833-7.
10. Warltier DC, Al-Wathiqui MH, Kampine JP, Schmeling WT. Recovery of contractile function of stunned myocardium in chronically instrumented dogs is enhanced by halothane or isoflurane. Anesthesiology 1988; 69: 552-65.
11. Marijic J, Stowe DF, Turner LA, Kampine JP, Bosnjak ZJ. Differential protective effects of halothane and isoflurane against hypoxic and reoxigenation injury in the isolated guinea pig heart. Anesthesiology 1990; 73: 976-83.
12. 2+ loading in intact hearts. Anesthesiology 2002; 96: 125-33.
13. Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982; 78: 206-9.
14. Mullane KM, Kraemer R, Smith B. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods 1985; 14: 157-67.
15. García-Criado FJ, Eleno N, Santos-Benito F, et al. Protective effect of exogenous nitric oxide on the renal function and inflammatory response in a model of ischemia-reperfusion. Transplantation 1998; 66: 982-90.
16. Lozano FS, García-Criado FJ, Fresnadillo MJ, García E, García JE, Gómez-Alonso A. Systemic inflammatory response induced by dacron graft and modulation by antimicrobial agents: experimental study. J Surg Res 2002; 107: 7-13.
17. Forman HJ, Boveris A. Superoxide radical and hydrogen peroxide in mitochondria. In: Pryor WA (Ed.). Free Radicals in Biology, vol V. New York: Academic Press; 1982; 5: 65-90.
18. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantites of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-54.
19. Misra HP, Fridovich Y. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 1972; 247: 3170-5.
20. Ansley DM, Sun J, Visser WA, et al. High dose propofol enhances red cell antioxidant capacity during CBP in humans. Can J Anesth 1999; 46: 641-8.
21. Yoo KY, Yang SY, Lee J, et al. Intracoronary propofol attenuates myocardial but not coronary endothelial dysfunction after brief ischaemia and reperfusion in dogs. Br J Anaesth 1999; 82: 90-6.
22. Cheng YJ, Wang YP, Chien CT, Chen CF. Small-dose propofol sedation attenuates the formation of reactive oxygen species in tourniquet-induced ischemia-reperfusion injury under spinal anesthesia. Anesth Analg 2002; 94: 1617-20.
23. Bao YP, Williamson G, Tew D, et al. Antioxidant effects of propofol in human hepatic microsomes: concentration effects and clinical relevance. Br J Anaesth 1998; 81: 584-9.
24. De La Cruz JP, Villalobos MA, Sedeño G, Sánchez de la Cuesta F. Effect of propofol on oxidative stress in an in vitro model of anoxia-reoxygenation in the rat brain. Brain Res 1998; 800: 136-44.
25. De La Cruz JP, Sedeño G, Carmona JA, Sánchez de la Cuesta F. The in vitro effects of propofol on tissular oxidative stress in the rat. Anesth Analg 1998; 87: 1141-6.
26. Corcoran TB, Engel A, Sakamoto H, et al. The effects of propofol on lipid peroxidation and inflammatory response in elective coronary artery bypass grafting. J Cardiothorac Vasc Anesth 2004; 18: 592-604.
27. Grasshoff C, Gillessen T. The effect of propofol on increased superoxide concentration in cultured rat cerebrocortical neurons after stimulation of N-methyl-D-aspartate receptors. Anesth Analg 2002; 95: 920-2.
28. Ross S, Muñoz H, Piriou V, Ryder A, Foex P. A comparison of the effects of fentanyl and propofol on left ventricular contractility during myocardial stunning. Acta Anaesthesiol Scand 1998; 42: 23-31.
29. Ebel D, Schlack W, Comfere T, Preckel B, Thamer V. Effect of propofol on reperfusion injury after regional ischaemia in the isolated rat heart. Br J Anaesth 1999; 83: 903-8.
30. Javadov SA, Lim KH, Kerr PM, Suleiman MS, Angelini GD, Halestrap AP. Protection of hearts from reperfusion injury by propofol is associated with inhibition of the mitochondrial permeability transition. Cardiovasc Res 2000; 45: 360-9.
31. Kowalski C, Zahler S, Becker BF, et al. Halothane, isoflurane, and sevoflurane reduce postischemic adhesion of neutrophils in the coronary system. Anesthesiology 1997; 86: 188-95.
32. Heindl B, Reichle FM, Zahler S, Conzen PF, Becker BF. Sevoflurane and isoflurane protect the reperfused guinea pig heart by reducing postischemic adhesion of polymorphonuclear neutrophils. Anesthesiology 1999; 91: 521-30.
33. De Hert SG, ten Broecke PW, Mertens E, et al. Sevoflurane but not propofol preserves myocardial function in coronary surgery patients. Anesthesiology 2002; 97: 42-9.
34. García-Criado FJ, Palma-Vargas JM, Valdunciel JJ, et al. Tacrolimus (FK506) down-regulates free radical tissue levels, serum cytokines, and neutrophil infiltration after severe liver ischemia. Transplantation 1997; 64: 594-8.
35. MacNaul KL, Hutchinson NI. Differential expression of iNOS and cNOS mRNA in human vascular smooth muscle cells and endothelial cells under normal and inflammatory conditions. Biochem Biophys Res Commun 1993; 196: 1330-4.
36. Beasley D, Schwartz JH, Brenner BM. Interleukin-1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells. J Clin Invest 1991; 87: 602-8.
37. Balligand JL, Ungureanu-Longrois D, Simmons WW, et al. Induction of NO synthase in rat cardiac microvascular endothelial cells by IL-1β and INF-γ. Am J Physiol 1995; 268: H1293-303.
38. Wang P, Zweier JL. Measurement of nitric oxide and peroxynitrite generation in the postischemic heart. Evidence for peroxynitrite-mediated reperfusion injury. J Biol Chem 1996; 271: 29223-30.
39. Xie QW, Kashiwabara Y, Nathan C. Role of transcription factor NF-κB/Rel in induction of nitric oxide synthase. J Biol Chem 1994; 269: 4705-8.
40. Chen RM, Wu GJ, Tai YT, et al. Propofol reduces nitric oxide biosynthesis in lipopolysaccharide-activated macrophages by downregulating the expression of inducible nitric oxide synthase. Arch Toxicol 2003; 77: 418-23.
41. Lowenthal JW, Ballard DW, Bohnlein E, Greene WC. Tumor necrosis factor alpha induces proteins that bind specifically to kappa B-like enhancer elements and regulate interleukin 2 receptor alpha-chain gene expression in primary human T lymphocytes. Proc Natl Acad Sci USA 1989; 86: 2331-5.
42. Osborn L, Kunkel S, Nabel GJ. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc Natl Acad Sci USA 1989; 86: 2336-40.